Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan Holders Can Proceed With Botox Suit, Judge Rules
Bloomberg
Monday, June 11, 2012 - 6:21pm
tags:
Botox, lawsuits, Allergan
Questcor: More Salespeople Boost Revenue
Seeking Alpha
Monday, June 11, 2012 - 6:20pm
tags:
Questcor, Acthar, drug reps
Winners Of ASCO 2012
Seeking Alpha
Monday, June 11, 2012 - 6:19pm
tags:
ASCO, Arqule, Array Biopharma, Astex, AstraZeneca, Bristol-Myers Squibb, GSK, Curis, Exelixis, Pfizer, Immunogen, Seattle Genetics, Sanofi, Synta
Celgene: Cancer Biotech For Accelerated Stock Growth
Seeking Alpha
Monday, June 11, 2012 - 6:16pm
tags:
Celgene
Johnson & Johnson wins US approval to buy Synthes
Reuters
Monday, June 11, 2012 - 6:13pm
tags:
JNJ, Synthes, M&A
Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma
Monday, June 11, 2012 - 1:17pm
tags:
Sanofi, Novo Nordisk, ADA, diabetes, Amylin, degludec, Lantus, Victoza
Ampio eye drug meets study goal, shares soar
Reuters
Monday, June 11, 2012 - 1:10pm
tags:
Ampio, Optina, retinal swelling, diabetes
Forest Labs cuts outlook on Lexapro discounts
Yahoo/AP
Monday, June 11, 2012 - 1:08pm
tags:
Forest Labs, Lexapro, guidance
Amgen Gets Supreme Court Review Of Stock Fraud Lawsuit
Bloomberg
Monday, June 11, 2012 - 1:07pm
tags:
Amgen, Supreme Court, stock fraud
Seattle Genetics Shares Continue To Impress - And It's Not Too Late To Buy
Seeking Alpha
Monday, June 11, 2012 - 1:05pm
tags:
Seattle Genetics
Amgen's Sensipar fails in late-stage trial
Pharma Times, UK
Monday, June 11, 2012 - 1:04pm
tags:
Amgen, Sensipar, kidney disease
Gilead: Truvada Will Pass FDA Approval
Seeking Alpha
Monday, June 11, 2012 - 1:00pm
tags:
Truvada, Gilead Sciences, FDA, HIV, Quad, Pfizer, Merck, GSK, Bristol-Myers Squibb
Protalix Receives a $25 Million Milestone Payment for U.S. Approval of ELELYSO(TM)
Yahoo
Monday, June 11, 2012 - 12:53pm
tags:
Protalix BioTherapeutics, Elelyso, Pfizer, Gaucher disease
Monday's Bio Pharma Momentum Movers And Buy-Out Speculation List
Seeking Alpha
Monday, June 11, 2012 - 11:26am
tags:
Alkermes, Amylin, Arena Pharmaceuticals, GSK, Human Genome Sciences, Obagi Medical Products
Lower Price of Benlysta Could Boost HGSI
Motley Fool
Monday, June 11, 2012 - 11:25am
tags:
Benlysta, Human Genome Sciences, GSK, lupus
Will Johnson & Johnson Strike it Rich With New Drug?
Wall St. Cheat Sheet
Monday, June 11, 2012 - 11:24am
tags:
JNJ, canagliflozin, diabetes
BioSante Tries Again to Show Female Libido Drug Works
Minyanville
Monday, June 11, 2012 - 11:20am
tags:
BioSante, female sexual dysfunction, LibiGel
J&J Said To Pay $2.2 Billion To End Risperdal Sales Probe
Bloomberg
Monday, June 11, 2012 - 10:48am
tags:
JNJ, Risperdal, settlements, antipsychotics
Novo's Victoza Leads To Greater Weight Loss Than Byetta
Bloomberg
Monday, June 11, 2012 - 10:47am
tags:
Byetta, diabetes, Victoza, Novo Nordisk, Amylin
Johnson & Johnson's Governance Issue
Seeking Alpha
Sunday, June 10, 2012 - 11:28am
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.